Autologous Transplant To End NMO Spectrum Disorder
Status:
Withdrawn
Trial end date:
2025-11-28
Target enrollment:
Participant gender:
Summary
This study is designed to treat your disease with an autologous stem cell transplant using a
regimen of immune suppressant drugs and chemotherapy to reset your immune system and to
determine if your disease will go into long-term remission.